Tag Archive: Biologics

Funding Opportunity: Nexus Award for Externships in Drug and Device Development


The Drugs, Biologics, Vaccines and Devices Translational Research Community of the Johns Hopkins Institute for Clinical and Translational Research is accepting applications for their Nexus Award Program.  The award strives to improve the research environment and career satisfaction of faculty by providing funds to investigators engaged in drugs, biologics, vaccines or device design. It is designed for investigators who wish to engage in short immersion experiences with colleagues at other academic research centers or industry partners. The award provides up to $25,000 including a maximum of $5,000 in travel, $200/day in support or replacement salary support. Applications are due on … Continue reading

Event: New Approaches to Metabolomics Research


Due to expected inclement weather, this event has been postponed. The Drugs, Biologics, Vaccines and Devices Translational Research Community of the Johns Hopkins Institute for Clinical and Translational Research’s (ICTR) and the Center for Metabolomics Analysis are hosting a symposium Tuesday, March 14 from 9:30 am-12:00 pm in Owens Auditorium at the Koch Cancer Research Building, 1550 Orleans St.  Event check-in and coffee service begin at 9:00am.  All faculty and staff are encouraged to attend. Keynote speakers include Charles Burant, MD, PhD director of the University of Michigan Nutrition Obesity Research Center (P30) and the Michigan Regional Comprehensive Metabolomics Resource … Continue reading

Drugs, Biologics, Vaccines and Devices


The Drugs, Biologics, Vaccines, and Devices community is lead by co-leaders Barbara Slusher and Clifford Weiss. The mission of the Drugs/Vaccines/Biologics/Devices Translational Research Community (TRC) is to stimulate highly innovative researchers and research programs that translate laboratory findings into new drug, device, or biologic therapeutics for human disease. We have been working to establish a vibrant and collaborative translational community for scientists across the Johns Hopkins Schools of Medicine, Public Health, Nursing, Engineering, and Arts and Sciences who are conducting research in these areas. The goals of the Drugs/Vaccines/Biologics/Devices TRC are to: Identify, support and enhance institutional capacity within the … Continue reading